-
1.发明授权
公开(公告)号：EP2170848B1
公开(公告)日：2014-10-22
申请号：EP08776162.3
申请日：2008-06-25
申请人： AstraZeneca AB
IPC分类号： C07D241/20 , C07D401/12 , C07D403/04 , C07D403/12 , C07D413/12 , A61K31/454 , A61P11/06
CPC分类号： C07D491/113 , C07D241/08 , C07D241/20 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/04 , C07D413/12 , C07D471/10
-
2.发明公开BENZOXAZINONE DERIVATIVES ACTING AS BETA2-ADRENORECEPTOR AGONIST FOR THE TREATMENT OF RESPIRATORY DISORDERS 审中-公开BENZOXAZINONDERIVATE ALS BETA2肾上腺素能受体激动剂治疗呼吸道疾病
公开(公告)号：EP2303873A1
公开(公告)日：2011-04-06
申请号：EP09766947.7
申请日：2009-06-17
申请人： AstraZeneca AB
发明人： BONNERT, Roger, Victor , CONNOLLY, Stephen , COOK, Anthony Ronald , EVANS, Richard , RAUBO, Piotr
IPC分类号： C07D413/12 , A61K31/538 , A61P11/00 , C07D231/12
CPC分类号： C07D231/12 , A61K31/538 , A61K45/06 , C07D413/12
摘要： The present invention provides a compound of formula (I), wherein W, R
1 , R
2 and R
3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.-
3.发明公开
公开(公告)号：EP2170848A1
公开(公告)日：2010-04-07
申请号：EP08776162.3
申请日：2008-06-25
申请人： AstraZeneca AB
IPC分类号： C07D241/20 , C07D401/12 , C07D403/04 , C07D403/12 , C07D413/12 , A61K31/454 , A61P11/06
CPC分类号： C07D491/113 , C07D241/08 , C07D241/20 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/04 , C07D413/12 , C07D471/10
摘要： The present invention relates to py razinone derivatives of formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are as herein defined; processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
-
公开(公告)号：EP1824838A1
公开(公告)日：2007-08-29
申请号：EP05810057.9
申请日：2005-11-28
申请人： AstraZeneca AB
发明人： EVANS, Richard , FORD, Rhonan , THOMPSON, Toby , WILLIS, Paul
IPC分类号： C07D401/04 , A61K31/47 , A61K31/4709 , A61K31/496 , A61P11/06 , A61P19/02 , A61P19/08 , A61P9/10 , C07D215/14 , C07D215/38 , C07D401/06 , C07D401/14 , C07D413/06
CPC分类号： C07D215/38 , C07D215/14 , C07D401/04 , C07D401/06 , C07D401/14 , C07D413/06
摘要： The invention provides compounds of formula (I), or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof, in which A, n, p, q, R1, R2, R3 and R4 are as defined in the specification; a process for their preparation; pharmaceutical compositions containing them; and their use in therapy.
摘要翻译： 本发明提供了式（I）化合物或其药学上可接受的盐或体内可水解的酯，其中A，n，p，q，R 1，R 2，R 3和R 4如说明书中所定义; 他们的准备过程; 含有它们的药物组合物 和它们在治疗中的用途。
-
-
-
搜索结果
4 条记录 (耗时 0.02 秒)
